<html>
<head>PUBMED IDs for VAMP-2</head>
<body bgcolor='#C5F0F2'><h1>VAMP-2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/10564647/'>Syntaxin 2 splice variants exhibit differential expression patterns, biochemical properties and subcellular localizations.</a> November 24  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/12130530/'>Vesicle-associated membrane protein 3 (VAMP-3) and VAMP-8 are present in human platelets and are required for granule secretion.</a> July 20  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/16306227/'>SV2A and SV2C are not vesicular Ca2+ transporters but control glucose-evoked granule recruitment.</a> November 25  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16443778/'>Impaired gene and protein expression of exocytotic soluble N-ethylmaleimide attachment protein receptor complex proteins in pancreatic islets of type 2 diabetic patients.</a> January 31  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/18253931/'>Vesicle associated membrane protein (VAMP)-7 and VAMP-8, but not VAMP-2 or VAMP-3, are required for activation-induced degranulation of mature human mast cells.</a> February 7  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18775748/'>Transient silencing of synaptic transmitter release from specific neuronal types by recombinant tetanus toxin light chain fused to antibody variable region.</a> September 9  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/25481410/'>MicroRNA-206 regulates surfactant secretion by targeting VAMP-2.</a> February 18  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25481381/'>Cross-talk between alpha1D-adrenoceptors and transient receptor potential vanilloid type 1 triggers prostate cancer cell proliferation.</a> July 15  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25659148/'>Identification of synaptosomal proteins binding to monomeric and oligomeric Î±-synuclein.</a> January 15  2015<br></body></html>
